Multi-indication Pembrolizumab Cost-effectiveness
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://data.mendeley.com/datasets/rcs5sbb445
下载链接
链接失效反馈官方服务：
资源简介：
This study aimed to perform a cost-effectiveness analysis evaluating 31 combinations of pembrolizumab use across five solid tumor indications—non-small cell lung cancer (NSCLC), Esophagus, Breast, Melanoma, and Cervical cancer—from the perspective of the Brazilian public health system. The model is uploaded with all data for analysis
创建时间：
2026-02-10
